Company Filing History:
Years Active: 2009-2019
Title: **Innovative Breakthroughs by Inventor Yunping Luo in Tumor-Targeted Drug Delivery**
Introduction
Yunping Luo, based in San Diego, California, is a notable inventor recognized for his significant contributions to the field of biomedical engineering. With a portfolio that includes five patents, he has focused his research primarily on developing innovative solutions for cancer treatment. His latest inventions showcase advancements in targeted drug delivery systems, particularly using nanoparticle technology.
Latest Patents
One of Yunping Luo's latest patents highlights a groundbreaking approach in nanoparticle-based tumor-targeted drug delivery. This aqueous tumor-targeting liposome nanoparticle composition consists of an aqueous dispersion of liposome nanoparticles designed to encapsulate anti-cancer chemotherapeutic agents. These nanoparticles can be either added to a pre-formed liposome composition or incorporated into liposomes during their formation.
The composition features a legumain-targeting lipid, which is mixed with various other micelle or vesicle-forming lipid materials. This innovative approach aids in delivering drugs specifically to tumor sites. A preferred formulation includes a legumain-targeting lipid component, polyethylene glycol-conjugated lipid component, zwitterionic lipids, amino-substituted lipids, and neutral lipids, ensuring effective targeting and uptake by cancer cells.
Career Highlights
Yunping Luo's career is marked by his affiliation with The Scripps Research Institute, an esteemed research institution known for its cutting-edge contributions to scientific discovery. Through his work, he has made a remarkable impact in the biomedical field, particularly in the development of novel drug delivery systems that enhance the efficacy of cancer treatments.
Collaborations
Throughout his career, Luo has collaborated with esteemed researchers, including Ralph A. Reisfeld and Rong Xiang. These partnerships have fostered a productive research environment, leading to advancements in understanding tumor biology and developing targeted therapies.
Conclusion
Yunping Luo stands out as an influential inventor in the realm of drug delivery innovations. His dedication to advancing cancer treatment through the development of nanoparticle-based systems marks him as a significant contributor to the field. With ongoing research and impressive collaborations, he continues to pave the way for future innovations that have the potential to transform cancer therapeutics.